Hepatitis B virus (HBV) contributes to hepatocellular carcinoma (HCC) development through
direct and indirect mechanisms. HBV DNA integration into the host genome occurs at early …

Chronic infection with the Hepatitis B Virus (HBV) is a major cause of liver-related morbidity
and mortality. One peculiar observation in cells infected with HBV (or with closely‑related …

With 296 million cases estimated worldwide, chronic hepatitis B virus (HBV) infection is the
most common risk factor for hepatocellular carcinoma (HCC). HBV-encoded oncogene X …

The pathogenesis of hepatocellular carcinoma (HCC) is poorly understood, but recent
advances in genomics have increased our understanding of the mechanisms by which …

At least 10 hepatitis B virus (HBV) genotypes (A to J) with distinct geographic distributions
and several HBV mutants, including precore/core promoter mutations and pre-S/S deletion …

Molecular epidemiologic studies reveal remarkable differences in the geographical
distribution of hepatitis B virus (HBV) genotypes. The frequency of mutants among HBV …

Purpose Postoperative prognosis of hepatitis B virus (HBV)–related hepatocellular
carcinoma (HCC) is poor. The effect of nucleotide/nucleoside analog (NA) treatment on the …

Hepatitis B virus (HBV) is a hepatotropic virus and an important human pathogen. There are
an estimated 296 million people in the world that are chronically infected by this virus, and …

Hepatitis B virus (HBV) infection is a major global health problem causing acute and chronic
liver disease that can lead to liver cirrhosis and hepatocellular carcinoma (HCC). HBV …

Currently available evidence supports a role for the hepatitis B virus (HBV) x gene and
protein in the pathogenesis of HBV‐induced hepatocellular carcinoma (HCC). HBx gene is …